AtriCure, Inc. (ATRC) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.44 -1.25%
EPS Growth %: +92.3%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +92.3%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q2 EPS of ($0.10), $0.09 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $25.03 million.
For earnings history and earnings-related data on AtriCure, Inc. (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Assurant (AIZ) is Piper Sandler's Weekly Focus Idea
- Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
